A multidisciplinary research team at the University of California, Irvine has revealed that the circadian clock – the biological pacemaker that governs daily rhythms in physiological processes, including immune functions – can be leveraged to enhance the efficacy of checkpoint inhibitor cancer therapy.
Study reveals pivotal role of the circadian clock in enhancing checkpoint inhibitor cancer therapy
- Thread starter Educator
- Start date